While the COVID-19 pandemic has shattered the world with severe human toll and catastrophic economic losses and sufferings, it has also heightened the need for more effective solutions for managing epidemic-related risks. In this paper, we pro- pose two capital market-based epidemic financing facilities to address two extremes of epidemic risks. The proposed pandemic bond is meant to hedge the severe pandemic outbreak while the proposed endemic swap can be used to hedge a recurrent endemic. Using coronavirus as an example of a pandemic and dengue fever as an example of an endemic, we discuss the modeling and pricing of the proposed epidemic securities. We price the proposed securities based on epidemiological models as well as actuarial models. We show that the proposed hedging securities can provide additional capital relief for pandemic recovery plans, effectively stablize hedgers’ cash flows, and create attractive returns to different investors.